# H. Miles Prince

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/h-miles-prince/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,742 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 79 |
| i10-index | 347 |
| Last Known Institution | The University of Melbourne |
| OpenAlex ID | https://openalex.org/A5031193094 |
| ORCID iD | https://orcid.org/0000-0002-0058-2448 |
| Works | 723 |

## Researcher papers

- [Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer](https://scholariq.org/papers/clinical-end-points-and-response-criteria-in-mycosis-fungoides-and-sezary/)
- [Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results](https://scholariq.org/papers/elranatamab-in-relapsed-or-refractory-multiple-myeloma-phase-2-magnetismm-3/)
- [Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model](https://scholariq.org/papers/cutaneous-lymphoma-international-consortium-study-of-outcome-in-advanced-stages/)
- [EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*](https://scholariq.org/papers/eortc-iscl-and-usclc-consensus-recommendations-for-the-treatment-of-primary/)
- [Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients](https://scholariq.org/papers/breast-implant-associated-anaplastic-large-cell-lymphoma-long-term-follow-up-of/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [The University of Melbourne](https://scholariq.org/institutions/the-university-of-melbourne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.